生物医学转化 (Dec 2021)

Research progress of incremental hemodialysis

  • Hu Weiwei,
  • Zhang Wenjun,
  • Qi Yuanyuan,
  • Wang Jianqin

DOI
https://doi.org/10.12287/j.issn.2096-8965.20210411
Journal volume & issue
Vol. 2, no. 4
pp. 80 – 84

Abstract

Read online

Hemodialysis therapy is the primary treatment for end-stage renal disease with the ultimate goal of improving quality of life and survival time. In the context of limited medical resources and the global prevalence of COVID-19, incremental hemodialysis, as a means of individualizing the dialysis regimen according to the patient's residual renal function, can not only better protect the residual renal function by individualizing the assessment of the patient's dialysis adequacy in multiple dimensions without affecting the hospitalization and survival rate, but also can reduce the medical burden and the risk of COVID-19 infection in hemodialysis patients. This review explains the concept, conditions of implementation, background, advantages and limitations of incremental hemodialysis, and aims to show that incremental hemodialysis will be an important strategy to achieve a balance among medical safety, survival, quality of life, and medical costs in the current medical and social environment in line with the requirements of precision medicine, and deserves further attention.

Keywords